AroCell announces today that Professor Gunnar Steineck has been appointed Chief Medical Officer at AroCell. Gunnar has been a temporary CMO for five months and now takes the role permanently. Gunnar has extensive experience as an oncologist and clinical researcher.
Gunnar Steineck has more than 35 years of experience in research in the medical field. After studying mathematics, statistics, and medicine at Uppsala University, he was trained as a specialist in oncology and radiation therapy at Karolinska University Hospital. After a Ph.D. (1990), Gunnar became an associate professor (1992). This was followed by post-doctoral studies at the Memorial Sloan-Kettering Cancer Center in New York. In 2002 he was appointed professor at Karolinska Institutet and in 2004 professor of clinical cancer epidemiology at the University of Gothenburg. The focus of his research since the 1990s has been to retrieve knowledge that can be used to cure cancer with restored health in the cancer survivor. Gunnar has more than 350 articles published in peer-reviewed journals. They include studies of markers, surgery, radiation therapy, and cytotoxic drugs.
“I have known Bernhard Tribukait since the 1980s, one of the two researchers behind AroCell's products”, says Gunnar Steineck. “Being able to help so that his important research regarding thymidine kinase benefits patients is a great joy”.
“I am very pleased that Gunnar is taking on this position permanently. His experience and knowledge in oncology, not least uro-oncology, are very valuable to AroCell. Gunnar has previously made significant contributions in his role as interim CMO and a board member as well as in specific consulting assignments ", says Anders Hultman, CEO of AroCell.